Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia

Z Li, Y Qiao, B Liu, EJ Laska, P Chakravarthi… - Clinical Cancer …, 2005 - AACR
Purpose: To test the feasibility, safety, immunogenicity, and clinical efficacy of an autologous
vaccine of leukocyte-derived heat shock protein 70-peptide complexes (Hsp70PC), in …
被引用次数：143 相关文章
[PDF] academia.edu

[PDF][PDF] Combination of Imatinib Mesylate with Autologous Leukocyte-Derived Heat Shock Protein and Chronic Myelogenous Leukemia

RD Bona, M Fang, U Hegde, V Moyo… - Clin Cancer …, 2005 - academia.edu
Purpose: To test the feasibility, safety, immunogenicity, and clinical efficacy of an autologous
vaccine of leukocyte-derived heat shock protein 70-peptide complexes (Hsp70PC), in …
[PDF] researchgate.net

[PDF][PDF] Combination of Imatinib Mesylate with Autologous Leukocyte-Derived Heat Shock Protein and Chronic Myelogenous Leukemia

RD Bona, M Fang, U Hegde, V Moyo… - Clin Cancer …, 2005 - researchgate.net
Purpose: To test the feasibility, safety, immunogenicity, and clinical efficacy of an autologous
vaccine of leukocyte-derived heat shock protein 70-peptide complexes (Hsp70PC), in …

[引用][C] Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia

Z LI - Clin Cancer Res., 2005 - cir.nii.ac.jp
Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and
chronic myelogenous leukemia | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia.

Z Li, Y Qiao, B Liu, EJ Laska… - … Cancer Research: an …, 2005 - europepmc.org
Purpose To test the feasibility, safety, immunogenicity, and clinical efficacy of an autologous
vaccine of leukocyte-derived heat shock protein 70-peptide complexes (Hsp70PC), in …

Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia

Z Li, Y Qiao, B Liu, EJ Laska… - Clinical Cancer …, 2005 - ohiostate.elsevierpure.com
Purpose: To test the feasibility, safety, immunogenicity, and clinical efficacy of an autologous
vaccine of leukocyte-derived heat shock protein 70-peptide complexes (Hsp70PC), in …

Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia

Z Li, Y Qiao, B Liu, EJ Laska… - … : an official journal …, 2005 - pubmed.ncbi.nlm.nih.gov
Purpose To test the feasibility, safety, immunogenicity, and clinical efficacy of an autologous
vaccine of leukocyte-derived heat shock protein 70-peptide complexes (Hsp70PC), in …

[引用][C] Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia

Z LI, YI QIAO, SH TANNENBAUM… - Clinical cancer …, 2005 - pascal-francis.inist.fr
Author ZIHAI LI 1 2; YI QIAO 1; TANNENBAUM, Susan H 2; MENORET, Antoine 1;
GAFFNEY, Judy 2; GLYNN, Laura 3; RUNOWICZ, Carolyn D 2; SRIVASTAVA, Pramod K 1 …
[PDF] academia.edu

[PDF][PDF] Combination of Imatinib Mesylate with Autologous Leukocyte-Derived Heat Shock Protein and Chronic Myelogenous Leukemia

RD Bona, M Fang, U Hegde, V Moyo… - Clin Cancer …, 2005 - academia.edu
Purpose: To test the feasibility, safety, immunogenicity, and clinical efficacy of an autologous
vaccine of leukocyte-derived heat shock protein 70-peptide complexes (Hsp70PC), in …

[引用][C] Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia

Z LI - Clin Cancer Res, 2005 - cir.nii.ac.jp
Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and
chronic myelogenous leukemia | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …